These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6309332)

  • 1. Spinal and supraspinal opioid analgesia in the mouse: the role of subpopulations of opioid binding sites.
    Ling GS; Pasternak GW
    Brain Res; 1983 Jul; 271(1):152-6. PubMed ID: 6309332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metkephamid (Tyr-D-ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: receptor binding and analgesic properties.
    Burkhardt C; Frederickson RC; Pasternak GW
    Peptides; 1982; 3(5):869-71. PubMed ID: 6294639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the affinity of naloxone at supraspinal and spinal opioid receptors in vivo: studies with receptor selective agonists.
    Heyman JS; Koslo RJ; Mosberg HI; Tallarida RJ; Porreca F
    Life Sci; 1986 Nov; 39(19):1795-803. PubMed ID: 3022095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
    Wolozin BL; Pasternak GW
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mu 1-opiate receptors in supraspinal opiate analgesia: a microinjection study.
    Bodnar RJ; Williams CL; Lee SJ; Pasternak GW
    Brain Res; 1988 Apr; 447(1):25-34. PubMed ID: 2838129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms.
    Ling GS; Spiegel K; Lockhart SH; Pasternak GW
    J Pharmacol Exp Ther; 1985 Jan; 232(1):149-55. PubMed ID: 2981312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
    Pick CG; Nejat RJ; Pasternak GW
    J Pharmacol Exp Ther; 1993 Apr; 265(1):166-71. PubMed ID: 8386234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.
    Pasternak GW
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3691-4. PubMed ID: 6251477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxazone, a long-acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro.
    Pasternak GW; Childers SR; Snyder SH
    J Pharmacol Exp Ther; 1980 Sep; 214(3):455-62. PubMed ID: 6105201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate analgesia: evidence for mediation by a subpopulation of opiate receptors.
    Pasternak GW; Childers SR; Snyder SH
    Science; 1980 May; 208(4443):514-6. PubMed ID: 6245448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modification of opiate receptor activity by arylsulfatase treatment.
    Garzón J; Jen MF; Lee NM
    Biochem Pharmacol; 1983 May; 32(9):1523-8. PubMed ID: 6134534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of receptor selective opioid peptides on morphine-induced analgesia.
    Barrett RW; Vaught JL
    Eur J Pharmacol; 1982 Jun; 80(4):427-30. PubMed ID: 6286328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opiate, enkephalin, and endorphin analgesia: relations to a single subpopulation of opiate receptors.
    Pasternak GW
    Neurology; 1981 Oct; 31(10):1311-5. PubMed ID: 6287349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
    Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.